542 related articles for article (PubMed ID: 24680950)
1. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
Keohane K; Brennan D; Galvin P; Griffin BT
Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
3. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
Klose D; Delplace C; Siepmann J
Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
[TBL] [Abstract][Full Text] [Related]
4. Controlling microencapsulation and release of micronized proteins using poly(ethylene glycol) and electrospraying.
Bock N; Dargaville TR; Woodruff MA
Eur J Pharm Biopharm; 2014 Jul; 87(2):366-77. PubMed ID: 24657821
[TBL] [Abstract][Full Text] [Related]
5. Formulations for modulation of protein release from large-size PLGA microparticles for tissue engineering.
Qodratnama R; Serino LP; Cox HC; Qutachi O; White LJ
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():230-6. PubMed ID: 25492193
[TBL] [Abstract][Full Text] [Related]
6. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
Mok H; Park TG
Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
[TBL] [Abstract][Full Text] [Related]
7. How porosity and size affect the drug release mechanisms from PLGA-based microparticles.
Klose D; Siepmann F; Elkharraz K; Krenzlin S; Siepmann J
Int J Pharm; 2006 May; 314(2):198-206. PubMed ID: 16504431
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
Feng R; Zhang Z; Li Z; Huang G
Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001
[TBL] [Abstract][Full Text] [Related]
9. Preparation of sustained release microparticles with improved initial release property.
Jung GY; Na YE; Park MS; Park CS; Myung PK
Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579
[TBL] [Abstract][Full Text] [Related]
10. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
Klose D; Siepmann F; Elkharraz K; Siepmann J
Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
[TBL] [Abstract][Full Text] [Related]
11. Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release.
Wu J; Kong T; Yeung KW; Shum HC; Cheung KM; Wang L; To MK
Acta Biomater; 2013 Jul; 9(7):7410-9. PubMed ID: 23535235
[TBL] [Abstract][Full Text] [Related]
12. Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray.
Lee YH; Mei F; Bai MY; Zhao S; Chen DR
J Control Release; 2010 Jul; 145(1):58-65. PubMed ID: 20346381
[TBL] [Abstract][Full Text] [Related]
13. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R
Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396
[TBL] [Abstract][Full Text] [Related]
14. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
16. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
Choi SH; Park TG
Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
[TBL] [Abstract][Full Text] [Related]
17. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
[TBL] [Abstract][Full Text] [Related]
18. A study of drug release from homogeneous PLGA microstructures.
Acharya G; Shin CS; Vedantham K; McDermott M; Rish T; Hansen K; Fu Y; Park K
J Control Release; 2010 Sep; 146(2):201-6. PubMed ID: 20381555
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system.
Lee BK; Yun YH; Choi JS; Choi YC; Kim JD; Cho YW
Int J Pharm; 2012 May; 427(2):305-10. PubMed ID: 22366486
[TBL] [Abstract][Full Text] [Related]
20. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin.
Patel B; Gupta V; Ahsan F
J Control Release; 2012 Sep; 162(2):310-20. PubMed ID: 22800582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
